Hummingbird Bioscience

About:

Hummingbird Bioscience focuses on the discovery and early development of oncology drugs.

Website: http://www.hummingbirdbioscience.com/en/

Twitter/X: hummingbirdbio

Top Investors: EDBI, Mirae Asset Venture Investment, Ally Bridge Group, Novo Holdings, Polaris Partners

Description:

Hummingbird Bioscience uses systems biology to develop insights into disease biology and applies computationally guided platforms to discover and engineer breakthrough biotherapeutics. The company is pursuing a broad pipeline of first drug candidates across multiple challenging targets with strong biological validation and disease association, including lead assets: HMBD-001, an anti-HER3 antibody, and HMBD-002, an anti-VISTA antibody, for the treatment of cancer. Hummingbird has established strategic collaborations with Cancer Research UK and Amgen, and has been awarded a product development grant from the Cancer Prevention and Research Institute of Texas.